Antrogen, Stem Cell Theme Rises 7.52% Up

On the 4th, the stem cell theme rose 3.39% compared to the previous day, showing strength, while Antrogen, a related stock drawing attention, surged 7.52% compared to the previous day. Antrogen is known as a developer and seller of stem cell therapeutics.

[Graph] Major Stocks' Price Changes in the Stem Cell Theme



According to provisional data compiled at 11:31, foreign investors have been making large net purchases of Antrogen, buying 15,400 shares.

[Table] Net Trading Volume of Foreign and Institutional Investors (Unit: 10,000 shares)



According to the analysis by Thinkpool Robo Algorithm RASSI, Antrogen’s quant financial score is 9.07 points, ranking 18th in the stem cell-related theme. This can be interpreted as Antrogen having relatively low investment attractiveness from a financial perspective. On the other hand, Donggu Bio Pharmaceutical ranked first in quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top Stocks by Financial Score within the Theme


※ The quant financial score is the result of the robo algorithm analyzing each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.